Recent Posts
- Ukraine recovery should be based on development of territorial communities, innovations, involvement of professional domestic community – results of ESUR forum 29.06.2023
- Ukraine repatriates five more seriously wounded Russian POWs 10.04.2023
- Rada intends to include history of Ukraine, foreign language in final certification for general secondary education 10.04.2023
- Rada terminates protocol on joint anti-terrorist measures in CIS territories for Ukraine 10.04.2023
- 100 Ukrainians, incl defenders of Mariupol, returned according to swap procedure – Yermak 10.04.2023
Pharma company Monfarm sees net profit rise by 85% in Q3 2021
KYIV. Oct 28 (Interfax-Ukraine) – Pharmaceutical company Monfarm (Cherkasy region) in July-September 2021 increased its net profit by 85.4% compared to the same period in 2020, to UAH 13.731 million.
According to the company’s report in the information disclosure system of the National Securities and Stock Market Commission, its net income in the third quarter increased by 16.93%, to UAH 139.856 million.
PJSC Monfarm was created in 1994 through corporatization and privatization of the state-owned enterprise Monastyrysche Pharmaceutical Plant, organized in 1986 on the basis of a distillery, as part of Kyiv pharmaceutical association Darnitsa.
Monfarm specializes in production of suppositories and tablet medicines, has more than 70 names of medicines of various pharmacotherapeutic groups.
According to the State Register, the ultimate beneficiary of the company is Yakiv Kuznetsov.
